Josephine M Egan Selected Research

helospectin I

6/2005

In vivo biological activity of exendin (1-30).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josephine M Egan Research Topics

Disease

34	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2002
20	Insulin Resistance 11/2022 - 01/2002
19	Obesity 01/2022 - 08/2003
11	Hyperglycemia 01/2018 - 03/2002
9	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 09/2002
7	Inflammation (Inflammations) 01/2021 - 03/2014
6	Body Weight (Weight, Body) 01/2020 - 06/2008
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2019 - 02/2010
5	Metabolic Diseases (Metabolic Disease) 11/2022 - 01/2008
5	Prediabetic State (Prediabetes) 07/2020 - 10/2013
5	Neoplasms (Cancer) 01/2020 - 02/2008
5	Weight Loss (Weight Reduction) 01/2016 - 10/2008
5	Hypoglycemia (Reactive Hypoglycemia) 03/2014 - 12/2008
4	Weight Gain 01/2022 - 01/2012
3	Diabetes Mellitus 01/2021 - 10/2007
3	Fatty Liver 01/2021 - 01/2019
3	Cognitive Dysfunction 01/2020 - 03/2008
3	Insulinoma 03/2016 - 07/2003
3	Abdominal Obesity 01/2016 - 08/2003
3	Glucose Intolerance 10/2007 - 01/2002
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 03/2003
2	Hypertrophy 01/2020 - 05/2011
2	Hyperinsulinism (Hyperinsulinemia) 11/2014 - 07/2004
2	Peripheral Nervous System Diseases (PNS Diseases) 05/2013 - 03/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2013 - 01/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2009 - 03/2002
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Hepatitis 12/2020
1	Non-alcoholic Fatty Liver Disease 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Ketosis 01/2020
1	Alcoholism (Alcohol Abuse) 01/2020
1	Endotoxemia 09/2019
1	Nausea 01/2019
1	Sarcopenia 01/2019
1	Atrophy 01/2018
1	Pain (Aches) 12/2017
1	Fatigue 01/2016
1	Lower Urinary Tract Symptoms 01/2016

Drug/Important Bio-Agent (IBA)

42	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2002
24	Insulin (Novolin)FDA Link 01/2021 - 01/2002
20	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 03/2002
10	Hormones (Hormone)IBA 01/2022 - 01/2002
10	Peptides (Polypeptides)IBA 12/2021 - 03/2002
10	Exenatide (Byetta)FDA Link 01/2019 - 03/2002
8	IncretinsIBA 01/2020 - 03/2003
7	Blood Glucose (Blood Sugar)IBA 03/2014 - 09/2002
6	SugarsIBA 01/2018 - 12/2008
6	AdiponectinIBA 01/2012 - 08/2003
5	LeptinIBA 04/2014 - 08/2003
5	Glucagon-Like Peptide-1 ReceptorIBA 02/2009 - 03/2002
4	CannabinoidsIBA 12/2020 - 01/2016
4	Glucagon (Glukagon)FDA Link 07/2014 - 03/2007
3	CurcuminIBA 11/2022 - 11/2014
3	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2019
3	CytokinesIBA 12/2020 - 07/2010
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2002
3	ResveratrolIBA 11/2014 - 10/2013
2	EnzymesIBA 12/2020 - 01/2015
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 05/2012
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020 - 03/2003
2	InflammasomesIBA 05/2019 - 01/2019
2	PolyphenolsIBA 01/2019 - 11/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 03/2014
2	Sweetening Agents (Sweeteners)IBA 01/2018 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 11/2014 - 03/2014
2	Saline SolutionIBA 07/2014 - 06/2009
2	Sirtuin 1IBA 10/2013 - 10/2013
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2013 - 10/2008
2	AdipokinesIBA 01/2012 - 07/2010
2	Glucagon-Like Peptides (Enteroglucagon)IBA 06/2009 - 06/2003
2	Hypoglycemic Agents (Hypoglycemics)IBA 02/2009 - 10/2003
2	Biological ProductsIBA 07/2003 - 03/2003
1	AntioxidantsIBA 11/2022
1	Protective AgentsIBA 11/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	ProinsulinIBA 12/2021
1	Therapeutic UsesIBA 01/2021
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021
1	KetonesIBA 01/2020
1	Disulfiram (Antabuse)FDA Link 01/2020
1	Rifaximin (L 105)FDA Link 09/2019
1	LipidsIBA 09/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2019
1	Insulin-Like PeptidesIBA 02/2019
1	Insulin-Like Growth Factor Binding Protein 2IBA 02/2019
1	Insulysin (Insulin-Degrading Enzyme)IBA 01/2019
1	Insulin ReceptorIBA 01/2018
1	Cocaine (Cocaine HCl)IBA 12/2017
1	EndocannabinoidsIBA 01/2017
1	Amylases FDA Link 06/2016
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2016
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2016
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 11/2015
1	Pioglitazone (Actos)FDA Link 11/2015

Therapy/Procedure

8	Therapeutics 01/2017 - 03/2002
4	Glycemic Control 01/2018 - 02/2009
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2014 - 05/2011